In 2023, hospital discharges for malignant neoplasm of the breast in the UK stood at a baseline from which future trends can be inferred. From 2024 to 2028, the forecast indicates a consistent decline in discharges from 23.94 thousand to 19.36 thousand, reflecting annual decreases of 4.93% in 2025, 5.11% in 2026, 5.57% in 2027, and 5.43% in 2028. The compound annual growth rate (CAGR) over this period is negative, illustrating a yearly average decrease aligning with healthcare advancements.

Future trends to watch for include:

Advancements in early detection and treatment potentially reducing discharge rates.
Changes in healthcare policies impacting hospital discharge data.
Technological improvements in outpatient care and telemedicine.